Logo image of PHM7.DE

ALTRIA GROUP INC (PHM7.DE) Stock Fundamental Analysis

FRA:PHM7 - Deutsche Boerse Ag - US02209S1033 - Common Stock - Currency: EUR

55.64  -0.67 (-1.19%)

Fundamental Rating

6

PHM7 gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 4 industry peers in the Tobacco industry. While PHM7 belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. PHM7 has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year PHM7 was profitable.
PHM7 had a positive operating cash flow in the past year.
In the past 5 years PHM7 has always been profitable.
PHM7 had a positive operating cash flow in each of the past 5 years.
PHM7.DE Yearly Net Income VS EBIT VS OCF VS FCFPHM7.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

1.2 Ratios

PHM7 has a Return On Assets of 27.10%. This is amongst the best in the industry. PHM7 outperforms 100.00% of its industry peers.
The Return On Invested Capital of PHM7 (37.10%) is better than 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for PHM7 is significantly above the industry average of 21.03%.
The last Return On Invested Capital (37.10%) for PHM7 is above the 3 year average (34.16%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 27.1%
ROE N/A
ROIC 37.1%
ROA(3y)22.85%
ROA(5y)16.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)34.16%
ROIC(5y)31.32%
PHM7.DE Yearly ROA, ROE, ROICPHM7.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

1.3 Margins

PHM7 has a better Profit Margin (37.13%) than 100.00% of its industry peers.
In the last couple of years the Profit Margin of PHM7 has grown nicely.
PHM7 has a Operating Margin of 51.20%. This is amongst the best in the industry. PHM7 outperforms 100.00% of its industry peers.
PHM7's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 61.41%, PHM7 perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
In the last couple of years the Gross Margin of PHM7 has grown nicely.
Industry RankSector Rank
OM 51.2%
PM (TTM) 37.13%
GM 61.41%
OM growth 3Y2.51%
OM growth 5Y3%
PM growth 3Y70.3%
PM growth 5YN/A
GM growth 3Y3.67%
GM growth 5Y3.35%
PHM7.DE Yearly Profit, Operating, Gross MarginsPHM7.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), PHM7 is creating value.
PHM7 has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, PHM7 has less shares outstanding
The debt/assets ratio for PHM7 is higher compared to a year ago.
PHM7.DE Yearly Shares OutstandingPHM7.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
PHM7.DE Yearly Total Debt VS Total AssetsPHM7.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

An Altman-Z score of 5.20 indicates that PHM7 is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.20, PHM7 belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
PHM7 has a debt to FCF ratio of 2.83. This is a good value and a sign of high solvency as PHM7 would need 2.83 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.83, PHM7 belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.83
Altman-Z 5.2
ROIC/WACC4.79
WACC7.75%
PHM7.DE Yearly LT Debt VS Equity VS FCFPHM7.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

2.3 Liquidity

A Current Ratio of 0.39 indicates that PHM7 may have some problems paying its short term obligations.
PHM7's Current ratio of 0.39 is on the low side compared to the rest of the industry. PHM7 is outperformed by 75.00% of its industry peers.
PHM7 has a Quick Ratio of 0.39. This is a bad value and indicates that PHM7 is not financially healthy enough and could expect problems in meeting its short term obligations.
PHM7 has a Quick ratio of 0.24. This is in the lower half of the industry: PHM7 underperforms 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.39
Quick Ratio 0.24
PHM7.DE Yearly Current Assets VS Current LiabilitesPHM7.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

3

3. Growth

3.1 Past

PHM7 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.54%, which is quite good.
PHM7 shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 4.03% yearly.
The Revenue has decreased by -1.86% in the past year.
The Revenue has been decreasing by -0.89% on average over the past years.
EPS 1Y (TTM)8.54%
EPS 3Y3.63%
EPS 5Y4.03%
EPS Q2Q%9.92%
Revenue 1Y (TTM)-1.86%
Revenue growth 3Y-2.62%
Revenue growth 5Y-0.89%
Sales Q2Q%0.25%

3.2 Future

PHM7 is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.38% yearly.
PHM7 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.73% yearly.
EPS Next Y8.1%
EPS Next 2Y5.41%
EPS Next 3Y4.63%
EPS Next 5Y3.38%
Revenue Next Year-1.17%
Revenue Next 2Y-0.59%
Revenue Next 3Y-0.48%
Revenue Next 5Y0.73%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PHM7.DE Yearly Revenue VS EstimatesPHM7.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B 20B 25B
PHM7.DE Yearly EPS VS EstimatesPHM7.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 12.10 indicates a correct valuation of PHM7.
PHM7's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.11, PHM7 is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 11.33, the valuation of PHM7 can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PHM7 is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of PHM7 to the average of the S&P500 Index (35.78), we can say PHM7 is valued rather cheaply.
Industry RankSector Rank
PE 12.1
Fwd PE 11.33
PHM7.DE Price Earnings VS Forward Price EarningsPHM7.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

75.00% of the companies in the same industry are more expensive than PHM7, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PHM7 is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 12.46
EV/EBITDA 10.79
PHM7.DE Per share dataPHM7.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PHM7 has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.49
PEG (5Y)3
EPS Next 2Y5.41%
EPS Next 3Y4.63%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.42%, PHM7 is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.41, PHM7 pays a better dividend. On top of this PHM7 pays more dividend than 100.00% of the companies listed in the same industry.
PHM7's Dividend Yield is rather good when compared to the S&P500 average which is at 2.39.
Industry RankSector Rank
Dividend Yield 6.42%

5.2 History

The dividend of PHM7 has a limited annual growth rate of 4.03%.
Dividend Growth(5Y)4.03%
Div Incr Years6
Div Non Decr Years6
PHM7.DE Yearly Dividends per sharePHM7.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

78.52% of the earnings are spent on dividend by PHM7. This is not a sustainable payout ratio.
PHM7's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP78.52%
EPS Next 2Y5.41%
EPS Next 3Y4.63%
PHM7.DE Yearly Income VS Free CF VS DividendPHM7.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B
PHM7.DE Dividend Payout.PHM7.DE Dividend Payout, showing the Payout Ratio.PHM7.DE Dividend Payout.PayoutRetained Earnings

ALTRIA GROUP INC

FRA:PHM7 (8/13/2025, 7:00:00 PM)

55.64

-0.67 (-1.19%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryTobacco
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)10-30 2025-10-30/bmo
Inst Owners63.51%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap93.72B
Analysts70.83
Price Target52.8 (-5.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.42%
Yearly Dividend3.4
Dividend Growth(5Y)4.03%
DP78.52%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.73%
Min EPS beat(2)0.61%
Max EPS beat(2)0.84%
EPS beat(4)2
Avg EPS beat(4)-0.51%
Min EPS beat(4)-2.78%
Max EPS beat(4)0.84%
EPS beat(8)2
Avg EPS beat(8)-2.07%
EPS beat(12)2
Avg EPS beat(12)-2.44%
EPS beat(16)2
Avg EPS beat(16)-2.52%
Revenue beat(2)0
Avg Revenue beat(2)-2.93%
Min Revenue beat(2)-4.94%
Max Revenue beat(2)-0.92%
Revenue beat(4)0
Avg Revenue beat(4)-2.55%
Min Revenue beat(4)-4.94%
Max Revenue beat(4)-0.92%
Revenue beat(8)0
Avg Revenue beat(8)-3.41%
Revenue beat(12)3
Avg Revenue beat(12)1.03%
Revenue beat(16)7
Avg Revenue beat(16)5.21%
PT rev (1m)2.23%
PT rev (3m)4.83%
EPS NQ rev (1m)-0.28%
EPS NQ rev (3m)-0.31%
EPS NY rev (1m)0%
EPS NY rev (3m)1.27%
Revenue NQ rev (1m)0.31%
Revenue NQ rev (3m)-0.66%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)-0.73%
Valuation
Industry RankSector Rank
PE 12.1
Fwd PE 11.33
P/S 4.61
P/FCF 12.46
P/OCF 12.25
P/B N/A
P/tB N/A
EV/EBITDA 10.79
EPS(TTM)4.6
EY8.27%
EPS(NY)4.91
Fwd EY8.83%
FCF(TTM)4.46
FCFY8.02%
OCF(TTM)4.54
OCFY8.16%
SpS12.07
BVpS-1.67
TBVpS-11.37
PEG (NY)1.49
PEG (5Y)3
Profitability
Industry RankSector Rank
ROA 27.1%
ROE N/A
ROCE 47.29%
ROIC 37.1%
ROICexc 39.06%
ROICexgc 179.29%
OM 51.2%
PM (TTM) 37.13%
GM 61.41%
FCFM 36.99%
ROA(3y)22.85%
ROA(5y)16.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)34.16%
ROIC(5y)31.32%
ROICexc(3y)39.35%
ROICexc(5y)36.18%
ROICexgc(3y)239.24%
ROICexgc(5y)176.2%
ROCE(3y)43.55%
ROCE(5y)39.93%
ROICexcg growth 3Y38.33%
ROICexcg growth 5Y47.52%
ROICexc growth 3Y4.11%
ROICexc growth 5Y13.18%
OM growth 3Y2.51%
OM growth 5Y3%
PM growth 3Y70.3%
PM growth 5YN/A
GM growth 3Y3.67%
GM growth 5Y3.35%
F-Score6
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.83
Debt/EBITDA 1.91
Cap/Depr 51.21%
Cap/Sales 0.63%
Interest Coverage 250
Cash Conversion 71.75%
Profit Quality 99.62%
Current Ratio 0.39
Quick Ratio 0.24
Altman-Z 5.2
F-Score6
WACC7.75%
ROIC/WACC4.79
Cap/Depr(3y)70.81%
Cap/Depr(5y)74.31%
Cap/Sales(3y)0.74%
Cap/Sales(5y)0.75%
Profit Quality(3y)109.56%
Profit Quality(5y)169.16%
High Growth Momentum
Growth
EPS 1Y (TTM)8.54%
EPS 3Y3.63%
EPS 5Y4.03%
EPS Q2Q%9.92%
EPS Next Y8.1%
EPS Next 2Y5.41%
EPS Next 3Y4.63%
EPS Next 5Y3.38%
Revenue 1Y (TTM)-1.86%
Revenue growth 3Y-2.62%
Revenue growth 5Y-0.89%
Sales Q2Q%0.25%
Revenue Next Year-1.17%
Revenue Next 2Y-0.59%
Revenue Next 3Y-0.48%
Revenue Next 5Y0.73%
EBIT growth 1Y4.83%
EBIT growth 3Y-0.18%
EBIT growth 5Y2.09%
EBIT Next Year6.39%
EBIT Next 3Y3.82%
EBIT Next 5Y1.64%
FCF growth 1Y1.75%
FCF growth 3Y1.5%
FCF growth 5Y2.55%
OCF growth 1Y0.83%
OCF growth 3Y1.36%
OCF growth 5Y2.24%